Anavar Results: Potential Muscle Gains and Body Changes

Oxandrolone, sold under the brand name Anavar, produces measurable but moderate changes in body composition: a gain in lean mass, a reduction in body fat (particularly around the abdomen), and improved muscle protein balance. Those effects are consistently documented in clinical trials, but the research participants are almost never healthy gym-goers chasing aesthetics. The bulk of the evidence comes from burn patients, people with HIV-related wasting, older adults losing muscle, and girls with Turner syndrome. That gap between the clinical evidence and the way Anavar is discussed in fitness culture is worth understanding, because it shapes what you can realistically expect and what risks you’d be accepting.

What the Research Shows About Lean Mass

The most consistent finding across studies is that oxandrolone improves net muscle protein balance. In young men given short-term oxandrolone, researchers observed increased skeletal muscle protein synthesis and better intracellular recycling of amino acids.¹ That’s the basic mechanism at work: the drug nudges the body toward building protein faster than it breaks it down.

In severely burned children, oxandrolone prevented the loss of fat-free mass that occurred in the placebo group. Patients on placebo lost a significant amount of lean tissue between admission and discharge, while those receiving oxandrolone held steady and actually gained fat-free mass over the following six months.² A follow-up study found that six months of oxandrolone treatment improved net muscle protein deposition by restoring how the leg muscles utilized amino acids.³

In burn rehabilitation specifically, patients receiving oxandrolone regained weight and lean mass two to three times faster than those on nutrition alone.⁴ A randomized trial in severe burn patients found that oxandrolone prevented the roughly 2 kg drop in lean body mass seen in the placebo group.⁵ These numbers are real, but they describe people in a catabolic crisis, burning through muscle at an alarming rate. The drug’s value there is largely about stopping the bleeding, not building a dramatically more muscular physique.

Fat Loss, Especially Around the Midsection

Oxandrolone’s effect on fat is arguably more striking than its effect on muscle. In a study of older men, oxandrolone reduced total body fat by about 1.8 kg, with roughly two-thirds of that loss coming from the trunk. Visceral fat, the deeper abdominal fat linked to metabolic disease, dropped substantially. Subcutaneous fat around the abdomen and thighs also decreased. These reductions came with improvements in estimated insulin sensitivity.⁶

A separate study compared oral oxandrolone to injectable testosterone and placebo in obese older men. After three months, the oxandrolone group had significantly greater losses in subcutaneous abdominal fat and lower levels of visceral fat compared to the other groups, even though body weight changes across the groups were similar.⁷ That last detail is important: the scale might not move much, but the mirror and the waist measurement tell a different story. Oxandrolone seems to preferentially redistribute composition toward less fat and more lean tissue rather than causing dramatic weight loss.

How Quickly Gains Disappear After Stopping

One of the less-discussed realities is how temporary the benefits are. In older men treated with oxandrolone for twelve weeks, lean body mass and muscle strength initially improved. But twelve weeks after stopping the drug, those gains had returned to baseline. The improvements were completely gone.⁸ This finding is a reality check for anyone imagining a short cycle that permanently transforms their physique. Without the ongoing anabolic stimulus, the body reverts.

The situation might differ somewhat in burn recovery, where one study found that lean mass gained during oxandrolone treatment was maintained after stopping, though the context there is fundamentally different: the body was rebuilding tissue it had lost, not adding tissue beyond its previous normal.⁴ For a healthy person using it to enhance physique, the older-men data is probably more relevant. The gains are a rental, not a purchase.

The HIV Wasting Data and Dose-Response

Some of the clearest dose-response information comes from a trial in HIV-positive men experiencing weight loss. This study tested placebo against 20, 40, and 80 mg daily doses of oxandrolone. All groups gained weight over 12 weeks, including placebo, but only the 40 mg group gained significantly more total weight than placebo, and only the 40 and 80 mg groups gained significantly more body cell mass (a proxy for metabolically active tissue). The relationship was not perfectly linear: going from 40 to 80 mg did not double the lean tissue gains.⁹

An earlier study found that HIV patients receiving 15 mg daily gained weight steadily over 16 weeks, while the placebo group continued losing weight. The 5 mg group mostly held stable. At those lower doses, the drug was well tolerated.¹⁰ Taken together, these studies suggest there is a floor below which oxandrolone does not do much and a ceiling above which you mostly collect side effects rather than additional muscle. The sweet spot in the clinical literature sits in the moderate range, though these doses were calibrated for wasting patients, not recreational users.

How Oxandrolone Affects Strength and Physical Function

Building lean tissue does not automatically translate into being stronger or more capable. In burned children, a study combining oxandrolone with exercise found that muscle strength increased significantly in the groups receiving oxandrolone, exercise, or both, compared to placebo with no exercise.¹¹ That sounds encouraging, but the comparison group was doing nothing. The question a gym-goer would ask is whether the drug adds anything on top of training.

A randomized trial in older women combining oxandrolone with resistance training addressed that question more directly. Strength, power, and functional measures like chair stands and dynamic balance all improved over time, but there was no significant difference between the group receiving oxandrolone plus training and the group receiving placebo plus training.¹² In other words, the exercise was doing the heavy lifting (literally), and the drug was not providing a meaningful additional boost in this population. The evidence that oxandrolone turns adequate training into exceptional training is thinner than the bodybuilding community tends to assume.

Liver Stress Is More Common Than Reported

Oxandrolone is a 17-alpha-alkylated steroid, which means it passes through the liver without being immediately broken down. That structural feature is what makes it effective as an oral drug, but it also means the liver takes the hit. A study of burn patients found that a striking 42% developed elevated liver enzymes (transaminitis) while on oxandrolone, and patients taking other liver-stressing medications at the same time were at higher risk.¹³ The authors noted that this rate was significantly higher than previously reported, which suggests earlier studies may have underestimated the problem.

Research in burn patients has confirmed that oxandrolone causes ALT and AST (liver enzymes) to rise, though in that particular study, actual liver function in terms of protein production was not impaired.¹⁴ Elevated enzymes without outright liver failure is still a warning sign. A systematic review of oxandrolone across various conditions recommended monitoring liver function throughout treatment because the drug can directly damage liver cells through oxidative stress and other mechanisms.¹⁵ Anavar has a reputation as the “mild” steroid, and compared to some others, liver toxicity may be less severe. But “milder than harsh” is not the same as safe.

Lipid Changes and Cardiovascular Concerns

Oxandrolone consistently disrupts cholesterol levels in a pattern that raises cardiovascular risk. The HIV wasting trial reported significant increases in LDL (“bad” cholesterol) and decreases in HDL (“good” cholesterol).⁹ In patients with elevated lipids, oxandrolone drove HDL below 40 mg/dL in a substantial proportion of participants, a level considered a risk factor for heart disease. Most patients also saw reciprocal rises in LDL.¹⁶

Animal data has shown the same pattern: oxandrolone-treated rats had about half the LDL cholesterol of controls, but also about 25% less HDL cholesterol.¹⁷ The drop in total cholesterol sounds beneficial on paper, but the simultaneous suppression of HDL flips the ratio in the wrong direction. For someone cycling Anavar for physique purposes over weeks or months, this lipid disruption accumulates. People with existing cardiovascular risk factors are playing with particularly poor odds.

Hormonal Suppression and Recovery

Even at low clinical doses, oxandrolone suppresses the body’s natural hormone production. In boys treated with synthetic androgens including oxandrolone, basal testosterone and FSH dropped significantly, and LH responses to stimulation were reduced by a third to nearly 90% after six months.¹⁸ Another study in boys with delayed puberty found that oxandrolone transiently suppressed the pituitary-testicular axis at three months, followed by a rebound at six and twelve months.¹⁹

In the HIV wasting trial, oxandrolone significantly suppressed sex hormone-binding globulin, LH, FSH, and both total and free testosterone levels.⁹ The idea that Anavar is too mild to shut down natural testosterone is one of the most persistent myths in fitness circles. It does suppress it. The degree and duration of suppression depend on dose and cycle length, and recovery may take time, especially for adult men using higher doses than those studied in the pediatric literature.

Effects Specific to Women

Oxandrolone is sometimes called the “female-friendly” steroid because its androgenic effects are weaker than testosterone’s. Research in girls with Turner syndrome, who were treated with growth hormone and oxandrolone, provides some of the best controlled data on what happens. At doses below 0.06 mg/kg/day, side effects were described as modest, but the most relevant safety concerns were virilization, including clitoromegaly and voice deepening, and a temporary delay in breast development.²⁰

On voice changes specifically, the higher dose produced a significant lowering of voice frequency, while the lower dose showed a trend toward lowering that was not quite statistically significant. About 11% of girls on the higher dose experienced voice frequency drops beyond the normal female range.²¹ Voice deepening from androgens can be irreversible. That risk exists even with a “mild” androgen, and it increases with dose and duration.

On the psychological side, a controlled study found that oxandrolone at conventional and low doses did not cause evident virilizing psychological effects in girls with Turner syndrome. Aggression, romantic interest, mood, and gender role behavior were not significantly affected by the drug.²² This is reassuring as far as it goes, but the doses studied were clinical, not the higher amounts sometimes used recreationally.

Bone, Collagen, and Wound Healing

Oxandrolone’s effects extend beyond muscle and fat. In boys with Klinefelter syndrome, two years of oxandrolone treatment improved cortical bone mass compared to placebo, with a meaningful gain in bone health index scores.²³ The picture is not uniformly positive, though. In a mouse burn model, oxandrolone did not protect against bone loss or improve bone mineral density recovery after injury.²⁴

At the cellular level, oxandrolone stimulated collagen production in immature bone-forming cells, but longer treatment in mature cells actually decreased collagen expression.²⁵ In wound-healing-relevant cells (fibroblasts on a collagen matrix simulating a healing wound), oxandrolone dramatically boosted the expression of procollagen, the precursor to structural collagen, with type III procollagen expression increasing roughly 11-fold.²⁶ This may partly explain why oxandrolone has been used clinically to support wound healing in burn patients, and why some users report improvements in skin quality and joint comfort, though that last observation comes from anecdote rather than controlled research.

Anxiety and Neurochemical Shifts

Animal research has raised a concern that is rarely discussed in fitness communities. In male rats, oxandrolone treatment induced pronounced anxiety-like behavior. The drug shifted brain chemistry in the amygdala toward an excitatory state: levels of calming neurochemicals like GABA, serotonin, and oxytocin dropped, while excitatory glutamate and dopamine rose.²⁷ Whether this translates directly to humans is uncertain, as rat neurobiology is not a perfect proxy. But it is a reminder that anabolic steroids are neuroactive compounds, not just muscle drugs, and mood changes during or after a cycle are biologically plausible even with a supposedly mild agent.

The same research found that co-administration of metformin, the common diabetes drug, partially reversed both the anxiety behavior and the neurochemical disruption. That finding is early-stage and has not been tested in human Anavar users, so treating it as a practical recommendation would be premature. But it does point toward a growing understanding that the psychological side effects of anabolic steroids may eventually be manageable through targeted interventions rather than just being dismissed as “roid rage.”

Why the Clinical Evidence Does Not Map Neatly to Gym Use

Almost every study cited here involves populations dealing with serious illness or developmental conditions: severe burns, HIV wasting, Turner syndrome, Klinefelter syndrome, or age-related muscle loss. These people are starting from a deficit. Their bodies are in a catabolic state, meaning they are breaking down tissue faster than they build it, and oxandrolone helps shift that balance back toward neutral or slightly positive. A healthy person who lifts weights and eats adequately is starting from a very different metabolic position.

A review of pharmacological interventions for burn recovery listed oxandrolone alongside testosterone, growth hormone, insulin, metformin, and propranolol as agents that improve skeletal muscle protein balance in severely burned patients.²⁸ That is a group of drugs with wildly different mechanisms. What they have in common is that they all help during a crisis. Whether oxandrolone provides similar value to someone who is already anabolically healthy is a question the clinical literature was never designed to answer. Some transfer of benefit is plausible, given the drug’s direct effects on protein synthesis. But the magnitude of physique change a healthy user sees will be smaller than what the burn-recovery or wasting-syndrome numbers might suggest, and those clinical numbers are already modest by bodybuilding expectations.

The combination of transient gains that disappear within months of stopping, consistent liver enzyme elevation, unfavorable lipid shifts, hormonal suppression, and possible mood effects adds up to a risk-benefit picture that looks much better in a clinical context (where the alternative is continued wasting) than in a recreational one (where the alternative is just training without pharmacological assistance). Understanding what oxandrolone actually does, rather than what gym lore claims, is the starting point for making an informed decision.